Post Marketing Clinical Study of Aripiprazole in Patients With Schizophrenia - Effects on Glucose Metabolism.
Phase of Trial: Phase IV
Latest Information Update: 19 May 2016
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- Sponsors Otsuka Pharmaceutical
- 10 Jun 2017 Biomarkers information updated
- 13 Jul 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 13 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.